The SVP & CFO of Universal Health (NYSE: UHS) is Selling SharesBy Carrie Williams
In addition to Steve Filton, 4 other UHS executives reported Sell trades in the last month.
Based on Universal Health’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $2.48 billion and quarterly net profit of $174 million. In comparison, last year the company earned revenue of $2.32 billion and had a net profit of $174 million. The company has a one year high of $139.77 and a one year low of $99.72. UHS’s market cap is $11.96B and the company has a P/E ratio of 17.34.
Based on 5 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $141.25, reflecting a -12.3% downside.
The insider sentiment on Universal Health has been negative according to 20 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Universal Health Services, Inc. operates as a healthcare management company, which through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. It operates through the Acute Care Hospital Services and Behavioral Health Care Services segments. The company was founded by Alan B. Miller in 1978 and is headquartered in King of Prussia, PA.